Skip to main content
SpringerLink
Log in
Book cover

Diabetic Retinopathy pp 53–75Cite as

Epidemiology of Diabetic Retinopathy

  • Chapter
  • First Online:

Abstract

Epidemiology is the study of factors that determine the occurrence and distribution of disease in a population. In studying the epidemiology of diabetic retinopathy (DR), the literature is large and can be difficult for the clinician to mentally organize. To help in this regard, we note that reports generally display information in grids that are multidimensional.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy. The Singapore Malay eye study. Ophthalmology. 2008;115:1869–1875.

    Article  PubMed  Google Scholar 

  2. Saaddine JB, Honeycutt AA, Narayan KM, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States 2005–2050. Arch Ophthalmol 2008;126:1740–1747.

    Article  PubMed  Google Scholar 

  3. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology. 1995;102:647–661.

    Google Scholar 

  4. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective diabetes study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med. 1998;128:165–175.

    Google Scholar 

  5. Klein R, Klein BEK, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: Feman SS, ed. Ocular Problems in Diabetes Mellitus. St. Louis: CV Mosby Co; 1989:255–264.

    Google Scholar 

  6. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103:1796–1806.

    Google Scholar 

  7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.

    Article  Google Scholar 

  8. Varma R, Torres M, Pena F, et al. Prevalence of diabetic retinopathy in adult Latinos. Am Acad Ophthalmol. 2004;111:1298–1306.

    Google Scholar 

  9. Zhang X, Gregg EW, Cheng YJ, et al. Diabetes mellitus and visual impairment. National health and nutrition examination survey, 1999–2004. Arch Ophthalmol. 2008;126:1421–1427.

    Article  PubMed  Google Scholar 

  10. Klein R, Klein B, Moss S, Cruickshanks K. The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217–1228.

    CAS  PubMed  Google Scholar 

  11. Skrivarhaug T, Fosmark DS, Stene LC, et al. Low cumulative incidence of proliferative diabetic retinopathy in childhood-onset type 1 diabetes: a 24 year follow-up study. Diabetologia. 2006;49:2281–2290.

    Article  CAS  PubMed  Google Scholar 

  12. Jekel JF, Elmore JG, Katz DL. Epidemiology, Biostatistics, and Preventive Medicine, 1st ed. Philadelphia: WB Saunders; 1996:216–217.

    Google Scholar 

  13. Vitale S, Maguire MG, Murphy RP, et al. Clinically significant macular edema in type I diabetes. Ophthalmology. 1995;102:1170–1176.

    CAS  PubMed  Google Scholar 

  14. Klein R, Sharrett AR, Klein BEK, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes. The atherosclerosis risk in communities study. Ophthalmology. 2002;109:1225–1234.

    Article  PubMed  Google Scholar 

  15. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema. Ophthalmology. 1984;91:1464–1474.

    CAS  PubMed  Google Scholar 

  16. Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96:1501–1510.

    CAS  PubMed  Google Scholar 

  17. Jaeschke R, Guyatt G, Barratt A, et al. Therapy and understanding the results. Measures of association. In: Guyatt G, Rennie D, eds. User’s Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice. Chicago: American Medical Association; 2002:351–368.

    Google Scholar 

  18. Kleinbaum DG, Klein M. Survival Analysis. A self-Learning Text. 2nd ed. New York: Springer; 2005:32–33.

    Google Scholar 

  19. Williams R, Airey M, Baxter H, et al. Epidemiology of diabetic retinopathy and macular edema: a systematic review. Eye. 2004;18:963–983.

    Article  CAS  PubMed  Google Scholar 

  20. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan eye study. Ophthalmology. 2009;116:461–467.

    Article  PubMed  Google Scholar 

  21. Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population-the Barbados eye study. Ophthalmology. 1999;106:1893–1899.

    Article  CAS  PubMed  Google Scholar 

  22. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101:1061–1070.

    CAS  PubMed  Google Scholar 

  23. Roy MS, Klein R, O’Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004;122:546–551.

    Article  PubMed  Google Scholar 

  24. National diabetes fact sheet, 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed November 30, 2008.

  25. Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract. 2006;74:301–308.

    Article  PubMed  Google Scholar 

  26. Raman R, Rani PK, Rachepalle SR, et al. Prevalence of diabetic retinopathy in India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–318.

    Google Scholar 

  27. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053.

    Article  PubMed  Google Scholar 

  28. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998;21:518–524.

    Article  CAS  PubMed  Google Scholar 

  29. Mundet X, Pou A, Piquer N, et al. Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain. Prim Care Diabetes. 2008;2:135–140.

    Article  PubMed  Google Scholar 

  30. Gupta R, Kumar P. Global diabetes landscape–type 2 diabetes mellitus in South Asia: epidemiology, risk factors, and control. Insulin. 2008;3:78–94.

    Article  Google Scholar 

  31. Raman R, Rani PK, Rachepalle SR, et al. Prevalence of diabetic retinopathy in India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2008;116:311–318.

    Google Scholar 

  32. Mitchell P, Smith W, Wang J, Attebo K. Prevalence of diabetic retinopathy in an older community/the blue mountain eye study. Ophthalmology. 1998;105:406–411.

    Article  CAS  PubMed  Google Scholar 

  33. Chen MS, Kao CS, Chang CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent subjects. Am J Ophthalmol. 1992;114:723–730.

    CAS  PubMed  Google Scholar 

  34. Chou P, Liao MJ, Kuo HS, et al. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care. 1994;17:1055–1058.

    Article  CAS  PubMed  Google Scholar 

  35. Wang K, Li T, Xiang H. Study on the epidemiological characteristics of diabetes mellitus and IGT in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 1998;19:282–285.

    CAS  PubMed  Google Scholar 

  36. Xie XW, Xu L, Wang YX, Jonas JB. Prevalence and associated factors of diabetic retinopathy. The Beijing eye study 2006. Graefe’s Arch Clin Exp Ophthalmol. 2008;246:1519–1526.

    Article  Google Scholar 

  37. Gadsby R. Epidemiology of diabetes. Adv Drug Deliv Rev. 2002;54:1165–1172.

    Article  CAS  PubMed  Google Scholar 

  38. Sinclair AJ, Gadsby R, Penfold S, et al. Prevalence of diabetes in care home residents. Diabetes Care. 2001;24:1066–1068.

    Article  CAS  PubMed  Google Scholar 

  39. Simmons D, Williams DRR, Powell MJ. Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. Br Med J. 1989;298:18–21.

    Article  CAS  Google Scholar 

  40. El Haddad O, Saad M. Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol. 1998;82:901–906.

    Article  CAS  PubMed  Google Scholar 

  41. Ezzati M, Vander Hoorn S, Lawes CMM, et al. Rethinking the “Diseases of Affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLos Med. 2005;2:e133.

    Article  PubMed  Google Scholar 

  42. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National health and nutrition examination survey, 1999 to 2004. J Am Coll Surg. 2008;207:928–934.

    Article  PubMed  Google Scholar 

  43. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350.

    Article  CAS  PubMed  Google Scholar 

  44. Moss SE, Klein R, Klein BEK. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105:998–1003.

    Article  CAS  PubMed  Google Scholar 

  45. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520–526.

    CAS  PubMed  Google Scholar 

  46. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527–532.

    CAS  PubMed  Google Scholar 

  47. Varma R. From a population to patients: the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 2008;115:1857–1858.

    Article  PubMed  Google Scholar 

  48. Trautner C, Icks A, Haastert B, et al. Incidence of blindness in relation to diabetes. Diabetes Care. 1997;20:1147–1153.

    Article  CAS  PubMed  Google Scholar 

  49. Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1–9.

    CAS  PubMed  Google Scholar 

  50. Roy MS, Skurnick J. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus. Arch Ophthalmol. 2007;125:1061–1067.

    Article  PubMed  Google Scholar 

  51. Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26:1731–1737.

    Article  PubMed  Google Scholar 

  52. van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population. The Hoorn study. Arch Ophthalmol. 2003;121:245–251.

    PubMed  Google Scholar 

  53. Cugati S, Cikamatana L, Wang JJ, et al. Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains eye study. Eye. 2006;20:1239–1245.

    Article  CAS  PubMed  Google Scholar 

  54. Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam eye study. Trans Am Ophthalmol Soc. 1997;95:329–350.

    CAS  PubMed  Google Scholar 

  55. Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects: 10 year follow-up from the diagnosis. J Diabetes Complicat. 2001;15:24–33.

    Article  CAS  PubMed  Google Scholar 

  56. Leske MC, Wu SY, Hennis A, et al. Incidence of diabetic retinopathy in the Barbados eye studies. Ophthalmology. 2003;110:941–947.

    Article  PubMed  Google Scholar 

  57. Porta M, Bandello F. Diabetic retinopathy. A clinical update. Diabetologia. 2002;45:1617–1634.

    Article  CAS  PubMed  Google Scholar 

  58. Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United ARab Emirates: a cross-sectional survey. BMC Ophthalmol. 2007;7:11–19.

    Article  PubMed  Google Scholar 

  59. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin epidemiologic study of diabetic retinopathy XXII. The twenty five year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859–1868.

    Article  PubMed  Google Scholar 

  60. Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in Urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46:2328–2333.

    Article  PubMed  Google Scholar 

  61. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study II. Diabetes. 1990;39:1116–1124.

    Article  CAS  PubMed  Google Scholar 

  62. Hamman RF, Mayer EJ, Moo-Young GA, et al. Prevalence and risk factors of diabetic retinopathy in non-hispanic whites and Hispanics with NIDDM. Diabetes. 1989;38:1231–1237.

    Article  CAS  PubMed  Google Scholar 

  63. Harris MI, Klein R, Cowie CC, et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican American than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care. 1998;21:1230–1235.

    Article  CAS  PubMed  Google Scholar 

  64. Emanuele N, Sacks J, Klein R, et al. Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care. 2005;28:1954–1958.

    Article  PubMed  Google Scholar 

  65. Munoz B, O'Leary M, Fonseca-Baker F, et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol. 2008;126:968–974.

    Article  PubMed  Google Scholar 

  66. Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes-the New Jersey 725 II. Risk factors. Arch Ophthalmol. 2000;118:105–115.

    CAS  PubMed  Google Scholar 

  67. Villalpando MAEG, Villalpando CG, Perez BA, Stern MP. Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. Arch Med Res. 1994;25:355–360.

    Google Scholar 

  68. Amini M, Parvaresh E. Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract. 2009;83:18–25.

    Article  PubMed  Google Scholar 

  69. Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global complication rates of type 2 diabetes in indigenous peoples: a comprehensive review. Diabetes Res Clin Pract. 2008;82:1–17.

    Article  PubMed  Google Scholar 

  70. Lim A, Stewart J, Chui TY, et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. Ophthalmic Epidemiol. 2008;15:402–409.

    Article  PubMed  Google Scholar 

  71. Wong J, Molyneaux L, Constantino M, et al. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31:1985–1990.

    Article  PubMed  Google Scholar 

  72. Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus. Arch Ophthalmol. 2006;124:1297–1306.

    Article  PubMed  Google Scholar 

  73. Bihan H, Laurent S, Sass C, et al. Association among individual deprivation, glycemic control, and diabetes complications: the EPICES score. Diabetes Care. 2005;28:2680–2685.

    Article  PubMed  Google Scholar 

  74. Bachmann MO, Eachus J, Hopper CD, et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use: a cross-sectional study. Diabetic Med. 2003;20:921–929.

    Article  CAS  PubMed  Google Scholar 

  75. Haffner SM, Mitchell BD, Moss SE, et al. Is there an ethnic difference if the effect of risk factors for diabetic retinopathy? Ann Epidemiol. 1993;3:2–8.

    Article  CAS  PubMed  Google Scholar 

  76. Sloan FA, Belsky D, Ruiz D Jr, Lee P. Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994–2005. Arch Ophthalmol. 2008;126:1548–1553.

    Article  PubMed  Google Scholar 

  77. Brown JB, Pedula KL, Summers KH. Diabetic retinopathy. Contemporary prevalence in a well-controlled population. Diabetes Care. 2003;26:2637–2642.

    Article  PubMed  Google Scholar 

  78. Rossing P. The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia. 2005;48:1439–1444.

    Article  CAS  PubMed  Google Scholar 

  79. Trautner C. Incidence of blindness in southern Gerany between 1990 and 1998. Diabetologia. 2001;44:147–150.

    Article  CAS  PubMed  Google Scholar 

  80. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116:497–503.

    Article  PubMed  Google Scholar 

  81. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26:1258–1264.

    Article  PubMed  Google Scholar 

  82. Klein R, Klein BE, Moss SE, Cruikshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102:7–16.

    CAS  PubMed  Google Scholar 

  83. Klein R, Klein BEK, Moss SE, et al. Diabetic macular edema. Ophthalmology. 1984;91:1464–1474.

    CAS  PubMed  Google Scholar 

  84. Wong TY, Klein R, Islam FMA, et al. Diabetic retinopathy in a multi-ethnic Cohort in the United States. Am J Ophthalmol. 2006;141:446–455.

    Article  PubMed  Google Scholar 

  85. Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of diabetic retinopathy in the Barbados eye studies. Arch Ophthalmol. 2006;124:250–255.

    Article  PubMed  Google Scholar 

  86. Krolewski AS, Warram JH, Rand LI, et al. Risk of proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a 40 year follow-up study. Diabetes Care. 1986;9:443–452.

    Article  CAS  PubMed  Google Scholar 

  87. Herman WH, Eastman RC. The effects of treatment on the direct costs of diabetes. Diabetes Care. 1998;21:C19–C24.

    PubMed  Google Scholar 

  88. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–932.

    Article  PubMed  Google Scholar 

  89. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–481.

    Article  PubMed  Google Scholar 

  90. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to medicare, 1991–2000. Am J Ophthalmol. 2006;142:976–982.

    Article  PubMed  Google Scholar 

  91. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–1760.

    Article  PubMed  Google Scholar 

  92. Happich M, Reitberger U, Breitscheidel L, et al. The economic burden of diabetic retinopathy in Germany in 2002. Graefe’s Arch Clin Exp Ophthalmol. 2008;246:151–159.

    Article  Google Scholar 

  93. Smith AF. The economic impact of ophthalmic services for persons with diabetes in the Canada province of Nova Scotia: 1993–1996. Ophthalmic Epidemiol. 2001;8:13–25.

    Article  CAS  PubMed  Google Scholar 

  94. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetes. Ophthalmology. 1989;96:255–264.

    CAS  PubMed  Google Scholar 

  95. Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the Federal government. Implications for health-care reform. Diabetes Care. 1994;17:909–917.

    Article  CAS  PubMed  Google Scholar 

  96. Matz H, Falk M, Gottinger W, Kieselbach G. Cost-benefit analysis of diabetic eye disease. Ophthalmologica. 1996;210:348–353.

    Article  CAS  PubMed  Google Scholar 

  97. Javitt J, Aiello L. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124:164–169.

    CAS  PubMed  Google Scholar 

  98. Sarin R. Criteria for deciding cost-effectiveness for expensive new anti-cancer agents. J Cancer Res Ther. 2008;4:1–2.

    Article  PubMed  Google Scholar 

  99. The Economist. Pocket World in Figures. London: Profile Books Ltd; 2008:236.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research, Retina Center, University of Minnesota, Posterior Segment Research, Phillips Eye Institute, Minneapolis, MN, 55404, USA

    Abdhish R. Bhavsar MD

  2. Retina Center, Minneapolis, MN, 55404, USA

    Geoffrey G. Emerson MD, PhD

  3. Phillips Eye Institute, Retina Center, Minneapolis, MN, 55404, USA

    M. Vaughn Emerson MD

  4. Charlotte Eye Ear Nose & Throat Associates, Charlotte, NC, 28210, USA

    David J. Browning MD, PhD

Authors
  1. Abdhish R. Bhavsar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geoffrey G. Emerson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Vaughn Emerson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David J. Browning MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdhish R. Bhavsar MD .

Editor information

Editors and Affiliations

  1. Throat Associates, Charlotte Eye Ear Nose &, Fairview Road 6035, Charlotte, 28210, USA

    David J. Browning

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bhavsar, A.R., Emerson, G.G., Emerson, M.V., Browning, D.J. (2010). Epidemiology of Diabetic Retinopathy. In: Browning, D. (eds) Diabetic Retinopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85900-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-85900-2_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-85899-9

  • Online ISBN: 978-0-387-85900-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation